Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 39,570 | 38,318 | 36,017 | 28,990 | 31,428 |
| Operating Income | -39,570 | -38,318 | -36,017 | -28,990 | -31,428 |
| Other Income | 3,263 | 3,752 | 4,054 | 3,979 | 3,098 |
| Pre-tax Income | -36,307 | -34,566 | -31,963 | -25,011 | -28,330 |
| Net Income Continuous | -36,307 | -34,566 | -31,963 | -25,011 | -28,330 |
| Net Income | $-36,307 | $-34,566 | $-31,963 | $-25,011 | $-28,330 |
| EPS Basic Total Ops | -0.52 | -0.49 | -0.45 | -0.37 | -0.49 |
| EPS Basic Continuous Ops | -0.52 | -0.49 | -0.45 | -0.37 | -0.48 |
| EPS Diluted Total Ops | -0.52 | -0.49 | -0.45 | -0.37 | -0.49 |
| EPS Diluted Continuous Ops | -0.52 | -0.49 | -0.45 | -0.37 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -0.49 | -0.45 | N/A | N/A |
| EBITDA(a) | $-40,900 | $-39,994 | $-38,041 | $-30,956 | $-33,288 |